Squarepoint Ops LLC Genprex, Inc. Transaction History

Squarepoint Ops LLC

  • $62.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.19 - $0.37 $22,379 - $43,580
117,786 New
117,786 $27,000
Q2 2021

Aug 16, 2021
SELL
$3.11 - $4.87 $115,660 - $181,115
-37,190 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$3.66 - $7.67 $136,115 - $285,247
37,190 New
37,190 $160,000
Q4 2020

Feb 16, 2021
SELL
$3.03 - $5.51 $48,619 - $88,413
-16,046 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$2.9 - $4.29 $46,533 - $68,837
16,046 New
16,046 $54,000

Others Institutions Holding GNPX

# of Institutions
2
Shares Held
600
Call Options Held
0
Put Options Held
0
View Full List

About Genprex, Inc.

GNPX Quotes by TradingView
  • Ticker GNPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,300
  • Market Cap $39.9M
  • Description
  • Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...
More about GNPX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email